A Clinical Study Using MEDI-551 in Adult Participants With Relapsed or Refractory Advanced B-Cell Malignancies
Clinical trial NCT00983619 · COMPLETED
Trial details
- NCT number
- NCT00983619
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-16
- Primary completion
- 2019-03-21
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.